Monoclonal Antibodies Targeting the Epidermal Growth Factor Receptor

By  

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 275-287

Bentham Science Publishers

Access to resources Recommend Favorite

Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study

By LoRusso Patricia   Krishnamurthi Smitha   Youssoufian Hagop   Hall Nancy   Fox Floyd   Dontabhaktuni Aruna   Grebennik Dmitri   Remick Scot  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 303-311

Springer Publishing Company

Access to resources Recommend Favorite

Effect of pH and Excipients on Structure, Dynamics, and Long-Term Stability of a Model IgG1 Monoclonal Antibody upon Freeze-Drying

By Park Jihea   Nagapudi Karthik   Vergara Camille   Ramachander Ranjini   Laurence Jennifer   Krishnan Sampathkumar  

Pharmaceutical Research, Vol. 30, Iss. 4, 2013-04 ,pp. : 968-984

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Arginine on Photostability and Thermal Stability of IgG1 Monoclonal Antibodies

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 8, 2009-12 ,pp. : 761-766

Bentham Science Publishers

Access to resources Recommend Favorite

OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model

By Tsimafeyeu Ilya   Zaveleva Elina   Stepanova Evgenia   Low Walter  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1436-1443

Springer Publishing Company

Access to resources Recommend Favorite